Tamponade in Surgery for Retinal Detachment Associated with Proliferative Vitreoretinopathy

Overview

Journal Cochrane Database Syst Rev

Publisher Wiley

Specialties General Medicine
Health Services

Date 2009 Oct 13

PMID 19821354

Citations 12

Authors

Stephen G Schwartz

Harry W Flynn Jr

Wen-Hsiang Lee

Elizabeth Ssemanda

Ann-Margret Ervin

Affiliations

Soon will be listed here.

Abstract

Background: Retinal detachment (RD) with proliferative vitreoretinopathy (PVR) often requires surgery. During surgery, a tamponade agent is needed to reduce the rate of recurrent retinal detachment.

Objectives: The objective of this review was to evaluate the benefits and adverse outcomes of surgery with various tamponade agents.

Search Strategy: We searched the Cochrane Controlled Register (CENTRAL), MEDLINE, EMBASE, Latin America and Carribbean Health Sciences (LILACS) and the UK Clinical Trials Gateway (UKCTG). There were no language or date restrictions in the search for trials. The electronic databases were last searched on 9 July 2009.

Selection Criteria: We included randomized clinical trials comparing patients treated with various tamponade agents.

Data Collection And Analysis: Two individuals screened the search results independently. One study with two trials was eligible for inclusion in the review.

Main Results: One study with two trials was included in the review. The first trial randomized 151 eyes to receive either silicone oil or sulfur hexafluoride (SF(6)) gas tamponades; the second trial randomized 271 eyes to receive either silicone oil or perfluropropane (C(3)F(8)) gas tamponades. In patients with RD associated with PVR, pars plana vitrectomy and infusion of either silicone oil or perfluropropane gas appear comparable for a broad variety of cases. Sulfur hexafluoride gas was associated with worse anatomic and visual outcomes than either silicone oil or perfluropropane gas.

Authors' Conclusions: The use of either C(3)F(8) or silicone oil appears reasonable for most patients with RD associated with PVR. Because there do not appear to be any major differences in outcomes between the two agents, the choice of a tamponade agent should be individualized for each patient.

Citing Articles

Impact of duration of silicone oil tamponade on foveal and parafoveal thickness in rhegmatogenous retinal detachment: a retrospective cohort study.

Ewais W, Ali L, Aboalazayem F Int Ophthalmol. 2024; 44(1):167.

PMID: 38565753 PMC: 10987340. DOI: 10.1007/s10792-024-03096-8.

Macular Edema Following Silicone Oil Tamponade for Retinal Detachment: A Literature Review.

Kontou E, Karakosta C, Kounas K, Iatropoulos I, Tsinopoulos I, Kozobolis V Cureus. 2024; 15(12):e51233.

PMID: 38283484 PMC: 10821764. DOI: 10.7759/cureus.51233.

Sexual quality of life after gynaecological cancer: what young women want.

Roussin M, Hamilton A, Lowe J, Martin L Qual Life Res. 2023; 33(3):679-689.

PMID: 38019323 DOI: 10.1007/s11136-023-03553-4.

Vitreous Substitutes from Bench to the Operating Room in a Translational Approach: Review and Future Endeavors in Vitreoretinal Surgery.

Confalonieri F, Josifovska N, Boix-Lemonche G, Stene-Johansen I, Bragadottir R, Lumi X Int J Mol Sci. 2023; 24(4).

PMID: 36834754 PMC: 9961686. DOI: 10.3390/ijms24043342.

Outcomes of Vitrectomy Combined with Scleral Buckling for Eyes with Early Recurrence of Simple Rhegmatogenous Retinal Detachment Previously Treated by Pars Plana Vitrectomy.

Tatsumi T, Baba T, Iwase T, Nizawa T, Miura G, Yokouchi H J Ophthalmol. 2021; 2020:6637143.

PMID: 33489337 PMC: 7803136. DOI: 10.1155/2020/6637143.

References

Cox M, Azen S, Barr C, Linton K, Diddie K, Lai M . Macular pucker after successful surgery for proliferative vitreoretinopathy. Silicone Study Report 8. Ophthalmology. 1995; 102(12):1884-91. DOI: 10.1016/s0161-6420(95)30779-8. View

Lean J, Azen S, Lopez P, Qian D, Lai M, McCuen B . The prognostic utility of the Silicone Study Classification System. Silicone Study Report 9. Silicone Study Group. Arch Ophthalmol. 1996; 114(3):286-92. DOI: 10.1001/archopht.1996.01100130282009. View

Tognetto D, Minutola D, Sanguinetti G, Ravalico G . Anatomical and functional outcomes after heavy silicone oil tamponade in vitreoretinal surgery for complicated retinal detachment: a pilot study. Ophthalmology. 2005; 112(9):1574. DOI: 10.1016/j.ophtha.2005.04.013. View

Gao R, Lu L, Zhang S, Tang S, Liu Q, Hu Z . Study on application of the silicone oil in the reattachment of complicated retinal detachment. Yan Ke Xue Bao. 1993; 9(3):146-8. View

Singh A, Glaser B, Lemor M, Michels R . Gravity-dependent distribution of retinal pigment epithelial cells dispersed into the vitreous cavity. Retina. 1986; 6(2):77-80. DOI: 10.1097/00006982-198600620-00002. View

Abrams G, Azen S, McCuen 2nd B, Flynn Jr H, Lai M, Ryan S . Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow-up. Silicone Study report 11. Arch Ophthalmol. 1997; 115(3):335-44. DOI: 10.1001/archopht.1997.01100150337005. View

Nawrocki J, Bogorodzki B . [Usefulness of different silicone oils for intraocular tamponade]. Klin Oczna. 1999; 100(5):295-300. View

Pertile G, Claes C . Silicone oil vs. gas for the treatment of full-thickness macular hole. Bull Soc Belge Ophtalmol. 2000; 274:31-6. View

McCuen 2nd B, Azen S, Stern W, Lai M, Lean J, Linton K . Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy. Silicone Study Report 3. Retina. 1993; 13(4):279-84. DOI: 10.1097/00006982-199313040-00002. View

10.

Brown G, Brown M, Sharma S, Busbee B, Landy J . A cost-utility analysis of interventions for severe proliferative vitreoretinopathy. Am J Ophthalmol. 2002; 133(3):365-72. DOI: 10.1016/s0002-9394(01)01423-4. View

11.

Charteris D, Sethi C, Lewis G, Fisher S . Proliferative vitreoretinopathy-developments in adjunctive treatment and retinal pathology. Eye (Lond). 2002; 16(4):369-74. DOI: 10.1038/sj.eye.6700194. View

12.

. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology. 1983; 90(2):121-5. DOI: 10.1016/s0161-6420(83)34588-7. View

13.

Eckardt C, Schmidt D, Czank M . Intraocular tolerance to silicone oils of different specific gravities. An experimental study. Ophthalmologica. 1990; 201(3):133-9. DOI: 10.1159/000310141. View

14.

Lu L, Li Y, Cai S, Yang J . Vitreous surgery in highly myopic retinal detachment resulting from a macular hole. Clin Exp Ophthalmol. 2002; 30(4):261-5. DOI: 10.1046/j.1442-9071.2002.00530.x. View

15.

. Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 1. Arch Ophthalmol. 1992; 110(6):770-9. DOI: 10.1001/archopht.1992.01080180042027. View

16.

Barr C, Lai M, Lean J, Linton K, Trese M, Abrams G . Postoperative intraocular pressure abnormalities in the Silicone Study. Silicone Study Report 4. Ophthalmology. 1993; 100(11):1629-35. DOI: 10.1016/s0161-6420(93)31425-9. View

17.

Krzystolik M, DAmico D . Complications of intraocular tamponade: silicone oil versus intraocular gas. Int Ophthalmol Clin. 2000; 40(1):187-200. DOI: 10.1097/00004397-200040010-00018. View

18.

Heimann H, Stappler T, Wong D . Heavy tamponade 1: a review of indications, use, and complications. Eye (Lond). 2008; 22(10):1342-59. DOI: 10.1038/eye.2008.61. View

19.

Diddie K, Azen S, Freeman H, Boone D, AABERG T, Lewis H . Anterior proliferative vitreoretinopathy in the silicone study. Silicone Study Report Number 10. Ophthalmology. 1996; 103(7):1092-9. DOI: 10.1016/s0161-6420(96)30562-9. View

20.

Tufail A, Schwartz S, Gregor Z . Prophylactic argon laser retinopexy prior to removal of silicone oil: a pilot study. Eye (Lond). 1997; 11 ( Pt 3):328-30. DOI: 10.1038/eye.1997.69. View